Clinical Research, Pharma & Healthcare FinancingMeiji Seika Pharma Invests in Centivax Universal VaccineBusiness WireMarch 31, 2026April 1, 2026 by Business WireMarch 31, 2026April 1, 2026011 Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office:...